15722-48-2

Olsalazine (Dipentium), an anti-inflammatory drug, is used in the treatment of inflammatory bowel disease. It is also a novel DNA hypomethylating agent.

Olsalazine-13C6 is intended for use as an internal standard for the quantification of olsalazine by GC- or LC-MS. Olsalazine (T20615) is an orally bioavailable prodrug form of the anti-inflammatory agent 5-aminosalicylic acid that is cleaved by bacterial azo reductases in the gut to generate active 5-ASA.1

Salicylic Acid-D4 (Standard) is a reference standard of Salicylic Acid-D4 intended for quantitative analysis, quality control, and related biochemical research applications. Salicylic Acid-d4 is a deuterated compound of Salicylic Acid.

Salicylic Acid-D4 is a deuterated compound of Salicylic Acid (TMSM-2075).

Salicylic acid (2-Hydroxybenzoic acid), a natural compound extracted from Willow bark, is an anti-inflammatory inhibitor of activity cyclooxygenase.

Salicylic acid (Standard) is the standard substance of Salicylic acid, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Salicylic acid (2-Hydroxybenzoic acid), a natural compound extracted from Willow bark, is an anti-inflammatory inhibitor of activity cyclooxygenase.

Salicylic Acid-[13C6] (Standard) is a reference standard of Salicylic Acid-[13C6] intended for quantitative analysis, quality control, and related biochemical research applications.

Olsalazine disodium (Dipentum) is bioconverted to 5-aminosalicylic acid (5-ASA) in the colon and has anti-inflammatory activity in ulcerative colitis.

Sodium salicylate (2-Hydroxybenzoic acid sodium salt), a metabolite of acetylsalicylic acid, can inhibit NF-kB and reduce oxidative stress.